EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Acutus Medical's enterprise value is $17.30 Mil.
Acutus Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $7.17 Mil. Therefore, Acutus Medical's EV-to-Revenue for today is 2.41.
The historical rank and industry rank for Acutus Medical's EV-to-Revenue or its related term are showing as below:
AFIB'
s EV-to-Revenue Range Over the Past 10 Years
Min: -3.18 Med: 2.12 Max: 212.12
Current: 2.49
During the past 6 years, the highest EV-to-Revenue of Acutus Medical was 212.12. The lowest was -3.18. And the median was 2.12.
AFIB's EV-to-Revenue is ranked better than 58.72% of 826
companies
in the Medical Devices & Instruments industry
Industry Median: 3.265
vs AFIB: 2.49
As of today (2024-05-12), Acutus Medical's stock price is $0.041.
Acutus Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.25. Therefore, Acutus Medical's PS Ratio for today is 0.16.
Acutus Medical EV-to-Revenue Historical Data
The historical data trend for Acutus Medical's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Acutus Medical's EV-to-Revenue
For the Medical Devices subindustry, Acutus Medical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acutus Medical's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Acutus Medical's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Acutus Medical's EV-to-Revenue falls into.
Acutus Medical's current Enterprise Value is $17.30 Mil.
Acutus Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.17 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acutus Medical (OTCPK:AFIB) EV-to-Revenue Explanation
Acutus Medical's share price for today is $0.041.
Acutus Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acutus Medical EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Acutus Medical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Acutus Medical (Acutus Medical) Business Description
Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AFIB has been successfully added to your 